1
0
0
(1 - 13 von 13
)
Oral Fingolimod or Intramuscular Interferon for Relapsing ...New England Journal of Medicine ·
www.nejm.org
von JA Cohen · · Zitiert von: — Guillermo Izquierdo, M.D., Klaus Tiel-Wilck, M.D., Ana de Vera, M.D.,. James Jin, Ph.D., Tracy Stites, Ph.D., Stacy Wu, M.D., ... › pdf
Short-term efficacy of Epley's manoeuvreBMJ ·
jnnp.bmj.com
von M von Brevern · · Zitiert von: 157 — Michael von Brevern, MD1,2; Torsten Seelig1,2; Andrea Radtke, MD1,2; Klaus Tiel-Wilck,. MD3; Hannelore Neuhauser, MD, MPH1,4, Thomas Lempert ... › jnnp full.pdf
A Positional Maneuver for Treatment of Horizontal‐Canal ...Wiley ·
onlinelibrary.wiley.com
von T Lempert · · Zitiert von: 518 — Klaus Tiel-Wilck MD,. From Neurologische Abteilung, Universitätsklinikum Rudolf Virchow, Berlin. Search for more papers by this author · Thomas Lempert MD,. › ...
Real-life outcomes of teriflunomide treatment in patients with ...Universität Bern ·
boris.unibe.ch
von BA Kallmann · · Zitiert von: 25 — Boris A. Kallmann, Klaus Tiel-Wilck, Jennifer S. Kullmann, Ulrich Engelmann and Andrew Chan on behalf of the TAURUS-MS study group. Abstract. › ...
Treatment of resistant MS spasticity with THC:CBD spray and ...NeuroTransData ·
www.neurotransdata.com
von M Freidel · Zitiert von: 2 — Matthias Freidel1, Klaus Tiel-Wilck2, Herbert Schreiber3, Michael Lang3. 1 MS-Zentrum, Kaltenkirchen, Germany; 2 MS Working Group, Berlin, Germany; ... › ...
Effectiveness and safety of opicapone in Parkinson's disease ...BioMed Central ·
translationalneurodegeneration.biomedcentral.com
von H Reichmann · · Zitiert von: 32 — ... Joachim Springub, Inga Suttrup Claus, Vera Tadic, Klaus Tiel-Wilck, Lars Tönges, Jens Tröger, Christoph Schrey, Alexander Schulze, ... › ...
TAURUS-MS observational study - CORECore.ac.uk ·
core.ac.uk
von BA Kallmann · · Zitiert von: 26 — Boris A. Kallmann, Klaus Tiel-Wilck, Jennifer S. Kullmann, Ulrich Engelmann and Andrew Chan on behalf of the TAURUS-MS study group. Abstract. › download › pdf
"Oral fingolimod or intramuscular interferon for relapsing ...Université catholique de Louvain ·
dial.uclouvain.be
von JA Cohen · · Zitiert von: — Guillermo Izquierdo, M.D., Klaus Tiel-Wilck, M.D., Ana de Vera, M.D.,. James Jin, Ph.D., Tracy Stites, Ph.D., Stacy Wu, M.D., ... › ...
Determination of Seminal Concentration of Fingolimod and ...National Institutes of Health (.gov) ·
pubmed.ncbi.nlm.nih.gov
von OJ David · · Zitiert von: 3 — Authors. Olivier J David , Amy Berwick , Nicole Pezous , Michael Lang , Klaus Tiel-Wilck , Tjalf Ziemssen , Peng Li , Hisanori Hara , Robert Schmouder ... › ...
Efficacy and Safety of Teriflunomide in SAGE Journalssagepub.com ·
journals.sagepub.com
von J Oh · · Zitiert von: 2 — Jiwon Oh, Sandra Vukusic, Klaus Tiel-Wilck, Jihad Said Inshasi, David Rog, Darren P Baker, Yelena Pyatkevich, Elizabeth M Poole, and Patrick ... › ...
Real-life outcomes of teriflunomide treatment in Europe PMCEurope PMC ·
europepmc.org
von BA Kallmann · · Zitiert von: 25 — Boris A. Kallmann, Klaus Tiel-Wilck, Jennifer S. Kullmann, Ulrich Engelmann, and Andrew Chan, on behalf of the TAURUS-MS study group ... › ...
Therapy satisfaction and adherence in patients with relapsing ...ДНТБ України ·
ouci.dntb.gov.ua
von R Haase · · Zitiert von: 53 — Boris A. Kallmann, Klaus Tiel-Wilck, Jennifer S. Kullmann, Ulrich Engelmann, Andrew Chan. https://doi.org · Full text. › ...
Letters to the Editor - AHA JournalsAHA Journals ·
www.ahajournals.org
von HW Kölmel · · Zitiert von: 1 — Klaus Tiel, MD. Department of Neurology. Rudolf Virchow Hospital. Free University Berlin. West Berlin, Federal Republic of Germany. References. › doi › pdf
Alle Infos zum Namen "Klaus Tiel-Wilck"
Verwandte Suchanfragen zu Klaus Tiel-Wilck
| Sandra Vukusic Jörg Osterhage Ludwig Kappos | Elke Becker Dorothea Becker Ulrich Engelmann | Christoph Schrey Alexander Schulze Joachim Springub |
Personen Vorname "Klaus" (65148) Name "Tiel-Wilck" (1) |
sortiert nach Relevanz / Datum